Sex differences in oral oxycodone self-administration and stress-primed reinstatement in rats.
Analgesics, Opioid
/ administration & dosage
Animals
Drug-Seeking Behavior
/ drug effects
Estrous Cycle
/ drug effects
Extinction, Psychological
/ drug effects
Female
Male
Naloxone
/ administration & dosage
Neurokinin-1 Receptor Antagonists
/ pharmacology
Oxycodone
/ administration & dosage
Prescription Drug Misuse
Rats
Rats, Wistar
Receptors, Neurokinin-1
/ physiology
Receptors, Opioid, mu
/ antagonists & inhibitors
Self Administration
opiate
reinstatement
self-administration
Journal
Addiction biology
ISSN: 1369-1600
Titre abrégé: Addict Biol
Pays: United States
ID NLM: 9604935
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
12
03
2019
revised:
08
07
2019
accepted:
18
07
2019
pubmed:
13
12
2019
medline:
29
9
2021
entrez:
13
12
2019
Statut:
ppublish
Résumé
The opioid epidemic has become a severe public health problem, with approximately 130 opioid-induced deaths occurring each day in the United States. Prescription opioids are responsible for approximately 40% of these deaths. Oxycodone is one of the most commonly abused prescription opioids, but despite its prevalent misuse, the number of preclinical studies investigating oxycodone-seeking behaviors is relatively limited. Furthermore, preclinical oxycodone studies that include female subjects are even more scarce, and it is critical that future work includes both sexes. Additionally, the oral route of administration is one of the most common routes for recreational users, especially in the early stages of drug experimentation. However, currently, only two studies have been published investigating operant oral oxycodone self-administration in rodents. Therefore, the primary goal of the present study was to establish an oral oxycodone operant self-administration model in adult male and female rats, as well as to examine a potential mechanism of stress-primed reinstatement. We found that females consumed significantly more oral oxycodone than males in operant self-administration sessions. We also found that active oxycodone self-administration was reduced by mu opioid receptor antagonism and by substitution of water for oxycodone solution. Lastly, we induced stress-primed reinstatement and found that this behavior was significantly attenuated by antagonism of the neurokinin-1 receptor, consistent with our prior work examining stress-induced reinstatement of alcohol- and cocaine-seeking.
Identifiants
pubmed: 31830773
doi: 10.1111/adb.12822
pmc: PMC7289656
mid: NIHMS1043007
doi:
Substances chimiques
Analgesics, Opioid
0
Neurokinin-1 Receptor Antagonists
0
Receptors, Neurokinin-1
0
Receptors, Opioid, mu
0
Naloxone
36B82AMQ7N
Oxycodone
CD35PMG570
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12822Subventions
Organisme : NIDA NIH HHS
ID : R00 DA039991
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 DA000531
Pays : United States
Informations de copyright
© 2019 Society for the Study of Addiction.
Références
J Pharmacol Exp Ther. 2014 Oct;351(1):2-8
pubmed: 25038175
Drug Alcohol Depend. 2004 Jun 11;74(3):265-72
pubmed: 15194204
Drug Alcohol Depend. 2013 Sep 1;132(1-2):95-100
pubmed: 23410617
Addict Behav. 2015 Feb;41:20-8
pubmed: 25282598
Psychopharmacology (Berl). 2017 Mar;234(6):977-987
pubmed: 28127624
NCHS Data Brief. 2009 Sep;(22):1-8
pubmed: 19796521
Pharmacol Biochem Behav. 2003 Feb;74(3):541-9
pubmed: 12543217
Sci Rep. 2018 Apr 3;8(1):5508
pubmed: 29615715
Nat Commun. 2017 Jan 10;8:13877
pubmed: 28072417
Genes Brain Behav. 2017 Sep;16(7):709-724
pubmed: 28523735
Psychopharmacology (Berl). 1999 May;144(1):77-82
pubmed: 10379627
Mol Psychiatry. 2018 Aug;23(8):1745-1755
pubmed: 28485408
Pharmacol Biochem Behav. 2002 May;72(1-2):431-5
pubmed: 11900816
Neuropsychopharmacology. 2013 May;38(6):976-84
pubmed: 23303056
Eur J Neurosci. 2019 Aug;50(3):2075-2085
pubmed: 29779230
J Pharmacol Exp Ther. 1984 May;229(2):481-6
pubmed: 6716270
Psychopharmacology (Berl). 2011 Nov;218(1):111-9
pubmed: 21340476
MMWR Morb Mortal Wkly Rep. 2015 Jul 10;64(26):719-25
pubmed: 26158353
Neuropharmacology. 2002 Dec;43(8):1258-68
pubmed: 12527475
J Addict Dis. 2004;23(4):1-9
pubmed: 15339710
Psychopharmacology (Berl). 2002 Feb;159(4):397-406
pubmed: 11823892
Mol Neurobiol. 2019 May;56(5):3603-3615
pubmed: 30155791
J Pain Symptom Manage. 2005 May;29(5 Suppl):S47-56
pubmed: 15907646
Psychopharmacology (Berl). 2016 Aug;233(15-16):2973-84
pubmed: 27318989
J Pharmacol Exp Ther. 1993 Jan;264(1):29-34
pubmed: 8423532
PLoS One. 2014 Jul 15;9(7):e101807
pubmed: 25025380
Birth Defects Res B Dev Reprod Toxicol. 2007 Apr;80(2):84-97
pubmed: 17342777
Med Care. 2016 Oct;54(10):901-6
pubmed: 27623005
J Vis Exp. 2012 Sep 15;(67):e4389
pubmed: 23007862
Biol Psychiatry. 2013 Apr 15;73(8):774-81
pubmed: 23419547
Neuropsychopharmacology. 2004 May;29(5):943-51
pubmed: 14872204
Neuropsychopharmacology. 2019 Jul;44(8):1415-1424
pubmed: 30555159
Neuropharmacology. 2015 Dec;99:106-14
pubmed: 26188146
Neuropsychopharmacology. 2014 Apr;39(5):1093-101
pubmed: 24173499
Clin Transl Oncol. 2007 May;9(5):298-307
pubmed: 17525040
Behav Brain Res. 1989 Nov 1;35(2):117-25
pubmed: 2818831
Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):618-27
pubmed: 16862602
ACS Chem Neurosci. 2017 May 17;8(5):1065-1073
pubmed: 28107783
Brain Res. 2001 Jun 29;905(1-2):254-8
pubmed: 11423104
Drug Alcohol Depend. 2007 Jul 10;89(2-3):183-9
pubmed: 17240083
JAMA Psychiatry. 2014 Jul 1;71(7):821-6
pubmed: 24871348
J Neurosci. 2003 Sep 10;23(23):8271-80
pubmed: 12967989
Behav Brain Res. 2017 Jun 1;327:155-161
pubmed: 28365196
Alcohol Clin Exp Res. 2001 Jul;25(7):1025-9
pubmed: 11505028
Trends Pharmacol Sci. 2013 Apr;34(4):206-14
pubmed: 23465410
Addict Biol. 2013 Mar;18(2):332-43
pubmed: 22260216
Eur J Pharmacol. 2016 Oct 15;789:75-80
pubmed: 27393461
Psychopharmacology (Berl). 2000 Dec;153(1):120-33
pubmed: 11255922
Eur J Pharmacol. 2008 Mar 17;582(1-3):78-87
pubmed: 18191832
Neuropharmacology. 2018 Aug;138:292-303
pubmed: 29936242
J Pain Palliat Care Pharmacother. 2012 Dec;26(4):348-61
pubmed: 23675595
Am J Drug Alcohol Abuse. 2011 Sep;37(5):313-23
pubmed: 21854273
PLoS One. 2014 May 05;9(5):e96547
pubmed: 24797666
J Pharmacol Exp Ther. 2012 Apr;341(1):225-32
pubmed: 22262924
Drug Alcohol Rev. 2017 Sep;36(5):633-638
pubmed: 28470826
Science. 1973 Dec 28;182(4119):1359-61
pubmed: 4128222
Vaccine. 2012 Jun 29;30(31):4617-24
pubmed: 22583811